Evaluation of dual-lumen pulmonary artery cannulation in extracorporeal right ventricular support

Read full text
Authors: Valeria Lo Coco, Michele Di Mauro, Silvia Mariani, Elham Bidar, Kasia Hryniewicz, Antonio Loforte, Thomas Fux, Samuel Heuts, Dominik Wiedemann, Michal Kawcynsky, Tom Verbelen, Lars Mikael Broman
+50 more Jamila Kremer, Mattéo Pozzi, Koji Takeda, Udo Boeken, Yih‐Sharng Chen, Paolo Masiello, Dominik J. Vogel, Jacinta J. Maas, Andrea Ballotta, Federico Pappalardo, Sandro Gelsomino, Roberto Lorusso, Jos G. Maessen, Opema Lohese, Davide Pacini, Sofia Martìn Suàrez, Luca Botta, Daniel Zimpfer, Anne‐Kristin Schaefer, Philipp Szalkiewicz, Bart P. Meyns, Marie De Vos, Leen Vercaemst, Matthias Karck, Anna Lassia Meyer, Ana Julia Holler, Matthias Jacquet‐Lagrèze, Jean François Obadia, Jean-Luc Fellahi, Amy S. Wang, Nikolaos Kalampokas, Artur Lichtenberg, Hug Aubin, Chih-Hsien Wang, Chun‐Cheng Huang, Heng‐Wen Chou, Severino Iesu, Generoso Mastrogiovanni, Vittoria Iennaco, Victoria M. Taylor, Nicholas A. Barret, Carlos V. Elzo Kraemer, Jorge E. López Matta, Jeroen J. Janson, Camilla L’Acqua, Fabiana L. Rossi, Antonella Bertera, Giulia Maj, Andrea Audo, Stephanie Bertolin
Cited by: 0
References: 15

Abstract

Objective To evaluate whether dual-lumen (DL) versus single-lumen (SL) pulmonary artery cannulation improves outcomes in patients with refractory right ventricular failure (RVF) supported with extracorporeal life support and to identify which patients benefit most. Methods We conducted a multicenter retrospective cohort study using the international PLACE registry (2000-2020). Adults undergoing pulmonary artery cannulation for isolated RVF were included. Outcomes were in-hospital and 30-day mortality, bleeding, thromboembolic events, continuous renal-replacement therapy, and length of stay. Propensity score weighting was applied to adjust for baseline differences. Prespecified analyses tested effect modification by hypoxemia, renal function, platelet count, cannulation site, and oxygenator use. Mediation and clustering were used to explore physiological pathways and phenotypes. Results Among 345 patients, DL cannulation was associated with lower postoperative lactate and creatinine and with fewer bleeding events. In weighted multivariable models, DL reduced the risk of bleeding and the composite of bleeding or thromboembolism (weighted odds ratio, 0.50; 95% CI 0.32-0.77; P = .0017 and weighted odds ratio, 0.57; 95% CI 0.39-0.84; P = .004). Hypoxemia significantly strengthened the survival benefit of DL, whereas cannulation site and oxygenator use did not modify outcomes. Mediation analyses indicated that the effect of DL on survival was indirect, operating through early improvement in perfusion and renal function. Unsupervised clustering identified distinct postoperative biochemical phenotypes with markedly different prognoses; DL was associated with a shift toward favorable profiles. Conclusions In extracorporeal life support for RVF, DL pulmonary artery cannulation improves outcomes primarily by enhancing early organ function and reducing complications. Patients with baseline hypoxemia appear to benefit most, supporting a physiology-guided approach to cannulation strategy.

Fields of Study & Subjects

Mechanical Circulatory Support Devices Respiratory Support and Mechanisms Transplantation: Methods and Outcomes

Publication details

Journal / source
JTCVS Open
Volume
30
Pages
101699–101699
Publication date
5 March 2026
Language
EN